Clinical trial
Mixed Chimeric Transplantation for Primary Amyloidosis
NCT00186095 · Stanford University, Other · Withdrawn
Key facts
| NCT number | NCT00186095 |
|---|---|
| Title | Mixed Chimeric Transplantation for Primary Amyloidosis |
| Official title | Mixed Chimeric Transplantation for Primary Amyloidosis |
| Lead sponsor | Stanford University, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Amyloidosis |
| Intervention type | Procedure |
| Interventions | autologous followed by nonmyeloablative allogeneic transplant |
| Enrollment | 0 |
| Start date | Dec 1, 2000 |
| Completion | Sep 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 23, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: